F.D.A. EXPEDITES REVIEW OF AMERICAN HOME'S CANCER DRUG
1 min read
F.D.A. EXPEDITES REVIEW OF AMERICAN HOME’S CANCER DRUG
American Home Products Corp says Food and Drug Administration will give expedited review to its experimental treatment for kidney cancer; FDA will review experimental drug, known as CCI-779, as treatment for renal-cell carcinoma after initial ther…